We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
-1.98%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.85B
AUM Growth
+$102M
Cap. Flow
+$208M
Cap. Flow %
7.28%
Top 10 Hldgs %
21.68%
Holding
535
New
168
Increased
71
Reduced
85
Closed
189

Top Buys

Rank Stock Value
1
SN icon
SharkNinja
SN
+$75.8M
2
DIS icon
Walt Disney
DIS
+$62.3M
3
KVUE icon
Kenvue
KVUE
+$55.7M
4
TGT icon
Target
TGT
+$51.2M
5
SMH icon
VanEck Semiconductor ETF
SMH
+$38.5M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$47.9M
2
VFC icon
VF Corp
VFC
+$40.9M
3
SPLK
Splunk Inc
SPLK
+$36.3M
4
BA icon
Boeing
BA
+$30.1M
5
JNJ icon
Johnson & Johnson
JNJ
+$26.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.36%
2 Technology 13.19%
3 Healthcare 9.24%
4 Industrials 8.98%
5 Communication Services 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBAY
201
DELISTED
Cymabay Therapeutics
CBAY
$2.07M 0.07%
+138,949
New +$1.84M
CBAY
202
PUT
DELISTED
Cymabay Therapeutics
CBAY
$2.01M 0.07%
+135,000
New +$1.79M
CARG icon
203
CarGurus
CARG
$3.27B
$1.99M 0.07%
+113,307
New +$2.24M
SLNO
204
DELISTED
Soleno Therapeutics
SLNO
$1.95M 0.07%
66,000
-54,799
-45% -$332K
PFE icon
205
Pfizer
PFE
$143B
$1.94M 0.07%
+58,429
New +$2.07M
NBIX icon
206
PUT
Neurocrine Biosciences
NBIX
$16.8B
$1.89M 0.07%
+16,800
New +$1.77M
AXP icon
207
PUT
American Express
AXP
$227B
$1.88M 0.07%
12,600
+11,900
+1,700% +$1.95M
RVMD icon
208
CALL
Revolution Medicines
RVMD
$39.9B
$1.87M 0.07%
+67,500
New +$2M
CYTK icon
209
Cytokinetics
CYTK
$10.5B
$1.78M 0.06%
60,289
-2,387
-4% -$79.5K
AZN icon
210
PUT
AstraZeneca
AZN
$263B
$1.77M 0.06%
+13,100
New +$1.79M
OIH icon
211
VanEck Oil Services ETF
OIH
$2.06B
$1.75M 0.06%
+5,069
New +$1.71M
NFLX icon
212
Netflix
NFLX
$299B
$1.72M 0.06%
+45,440
New +$1.93M
CTRN icon
213
Citi Trends
CTRN
$555M
$1.7M 0.06%
+76,457
New +$1.56M
AVDL
214
DELISTED
Avadel Pharmaceuticals
AVDL
$1.68M 0.06%
163,382
+134,609
+468% +$1.8M
LVS icon
215
Las Vegas Sands
LVS
$31.7B
$1.61M 0.06%
+35,127
New +$1.9M
ARKK icon
216
ARK Innovation ETF
ARKK
$5.64B
$1.59M 0.06%
+40,025
New +$1.76M
SNAP icon
217
CALL
Snap
SNAP
$7.89B
$1.56M 0.05%
+175,000
New +$1.83M
INGN icon
218
Inogen
INGN
$175M
$1.55M 0.05%
+296,901
New +$2.11M
GT icon
219
Goodyear
GT
$2B
$1.52M 0.05%
122,665
+1,971
+2% +$26.8K
EDR
220
DELISTED
Endeavor Group Holdings, Inc.
EDR
$1.48M 0.05%
+74,376
New +$1.71M
ALKS icon
221
Alkermes
ALKS
$8.22B
$1.48M 0.05%
+52,836
New +$1.55M
METCB icon
222
Ramaco Resources Class B
METCB
$425M
$1.4M 0.05%
126,597
+13,121
+12% +$147K
AKRO
223
PUT
DELISTED
Akero Therapeutics
AKRO
$1.37M 0.05%
+27,000
New +$1.26M
CELC icon
224
Celcuity
CELC
$4.21B
$1.36M 0.05%
148,500
+13,500
+10% +$133K
TVTX icon
225
Travere Therapeutics
TVTX
$5.2B
$1.31M 0.05%
+146,742
New +$2.07M
7 8
9
10 11

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $3.44B AUM 9.15% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

J. Goldman & Co's Q3 2023 Portfolio in Review

As of Q3 2023, J. Goldman & Co held 535 positions worth $2.85B, up 3.7% from $2.75B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $208M of net new capital in Q3 2023, opening 168 new positions and adding to 71 existing holdings. Its largest new stake was SharkNinja: 2,071,888 shares worth $96.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $47.9M trimmed.

  • J. Goldman & Co's largest Q3 2023 buy was SharkNinja: 2,071,888 shares worth $96.1M.
  • J. Goldman & Co added most to PayPal in Q3 2023, an estimated $34.3M increase.
  • J. Goldman & Co's biggest Q3 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $47.9M.
  • J. Goldman & Co fully exited VF Corp in Q3 2023, selling an estimated $40.9M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2023.
  • J. Goldman & Co opened 168 new positions and closed 189 in Q3 2023.
  • J. Goldman & Co's portfolio value rose 3.7% quarter-over-quarter to $2.85B.

Based on J. Goldman & Co's 13F filing for Q3 2023, filed 14 Nov 2023.